✦ LIBER ✦

Double duty for nuclear proteins – the price of more open forms of mitosis

✍ Scribed by Colin P. De Souza; Stephen A. Osmani

Book ID: 113933068
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 457 KB
Volume: 25
Category: Article
ISSN: 0168-9525
DOI: 10.1016/j.tig.2009.10.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CELL BIOLOGY:Nuclear Transport Protein D

CELL BIOLOGY:Nuclear Transport Protein Does Double Duty in Mitosis

✍ Pennisi, E. 📂 Article 📅 1999 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 394 KB

Nuclear Factor-90 of Activated T-Cells:

Nuclear Factor-90 of Activated T-Cells: A Double-Stranded RNA-Binding Protein and Substrate for the Double-Stranded RNA-Dependent Protein Kinase, PKR

✍ Langland, J. O.; Kao, P. N.; Jacobs, B. L. 📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 100 KB

Unphosphorylated and tyrosine-phosphoryl

Unphosphorylated and tyrosine-phosphorylated forms of a focal adhesion protein, paxillin, are substrates for calpain II in vitro: Implications for the possible involvement of calpain II in mitosis-specific degradation of paxillin

✍ Ryuji Yamaguchi; Masatoshi Maki; Masakazu Hatanaka; Hisataka Sabe 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Phosphorylation of H2AX histone as indir

Phosphorylation of H2AX histone as indirect evidence for double-stranded DNA breaks related to the exchange of nuclear proteins and chromatin remodeling inChara vulgarisspermiogenesis

✍ A. Wojtczak; K. Popłońska; M. Kwiatkowska 📂 Article 📅 2008 🏛 Springer Vienna 🌐 English ⚖ 242 KB

Prospective, Randomized, Double-Blind, V

Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia

✍ Coplen, D.E. 📂 Article 📅 2013 🏛 Elsevier Science ⚖ 48 KB

Prospective, Randomized, Double-Blind, V

Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia

✍ Elhilali, Mostafa M.; Pommerville, Peter; Yocum, Richard C.; Merchant, Rosemina; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 811 KB